A prospective multi-center investigational study of IMMray

Build status - In Progress

Enrolling By Invitation

18 years - 99 years

All

Phase N/A

1 Location

Brief description of study

Brief Summary: PanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups. The goals of the study are to assess the performance and diagnostic accuracy of the IMMray™ PanCan-d test compared to standard-of-care imaging.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: pancreas
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 831292

If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research